Diagnostic Evaluation
Diagnostic
studies that relate to the male reproductive organs and the ability to
participate in sexual activity include the following.
The
prostate gland produces a substance known as prostate-specific antigen (PSA). It can be measured in a blood specimen,and
levels increase with prostate cancer. Many factors can increase PSA levels,
including BPH, prostate cancer, and infections of the prostate and urinary
tract. PSA levels are measured in nanograms per milliliter (ng/mL). The PSA
test and DRE are used to detect prostate cancer (Smith, Cokkinides, von
Eschenbach, et al., 2002).
The
range of values considered normal is 0.2 to 4.0 ng/mL. Values over 4.0 are
considered elevated. An elevated PSA level is not a specific indicator of
prostate cancer. A number of condi-tions (eg, BPH, transurethral resection of
the prostate, acute uri-nary retention, and acute prostatitis) can also cause
an elevated PSA level in the absence of prostate cancer. Despite these
limita-tions, in combination with other procedures, PSA is useful in
identifying men at risk and in monitoring patients following treatment for
cancer of the prostate (Barry, 2001). A PSA test, along with DRE, is
recommended by the American Cancer So-ciety annually for men at high risk,
specifically those with a fam-ily history of prostate cancer and for African
American men.
Transrectal ultrasound (TRUS) studies may be
performed in pa-tients with abnormalities detected by DRE or those with
elevated PSA levels. After DRE, a lubricated, condom-covered, rectal probe
transducer is inserted into the rectum along the anterior wall. Water may be
introduced to the condom to help transmit sound waves to the prostate. TRUS may
be used in detecting nonpal-pable prostate cancers and in staging localized
prostate cancer. Needle biopsies of the prostate are commonly guided by TRUS.
Specimens of prostate fluid or tissue may be
obtained for culture when disease or inflammation of the prostate gland is
suspected. A biopsy of the prostate gland may be necessary to obtain tissue for
histologic examination. This may be performed at the time of prostatectomy or
by means of a perineal or transrectal needle biopsy.
If the
patient cannot engage in sexual intercourse to his satisfac-tion, a detailed
history is obtained. Nocturnal penile tumescence tests may be conducted in a
sleep laboratory to monitor changes in penile circumference during sleep (using
a mercury strain gauge placed around the penis); the results help to identify
the cause of erectile dysfunction. Arterial blood flow to the penis is measured
with the Doppler probe. Nerve conduction tests and psychologi-cal evaluations
are also part of the diagnostic workup and are usu-ally conducted by a
specialized team of health care providers.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.